News Nissan stays in UK - but will Japanese pharma? Japanese R&D investment could follow EMA out of UK - experts.
News ‘Smart’ pillbox wins Takeda depression challenge EllieGrid improves medication adherence by reminding patients when to take medicines.
News Takeda earmarks $15 billion for M&A - reports Japanese company could be on the acquisition trail.
News Adcetris falls victim to NICE’s Cancer Drugs Fund clear-out More CDF legacy products likely to face same fate
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
